• Editor-in-Chief

    Rafael Franco, PhD

    Professor of Biochemistry and Molecular Biology, Universidad de Barcelona, Barcelona, Spain.
    Email: rfranco123@gmail.com
    Associate Editors

    Abdelhamid Benazzouz, PhD

    Section: Brain stimulation
    Research Director, Team Leader, Neurochemistry, Deep brain stimulation & Parkinson’s disease, Neurodegenerative Diseases Institute, Bordeaux University, Bordeaux, France

    Raymond Chuen-Chung Chang, PhD

    Section: Neuroimmunology
    Associate Professor, Laboratory of Neurodegenerative Diseases, School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China

    Ta-Yuan (T.Y.) Chang, PhD

    Section: Neurological alterations caused by cholesterol dyshomeostasis
    Professor, Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire, USA

    Volker Dietz, MD, FRCP, FEAN

    Section: Spinal cord injury
    Professor (emeritus) and Senior Research Fellow at Spinal Cord Injury Center, Balgrist University Hospital, Zurich, Switzerland

    Yuchuan Ding, MD, PhD

    Section: Cerebral ischemia/haemorrhagic stroke
    Professor and Vice Chair for Research, Director of Cerebrovascular Research Labs, Department of Neurosurgery, Wayne State University School of Medicine, Michigan, USA

    Paolo Follesa,

    Section: Astroglia-mediated neuroprotection
    Professor of Pharmacology and Neurogenomics at the Department of life and environmental sciences (Di.S.V.A.), University of Cagliari, Cagliari, Italy

    Shile Huang, PhD

    Section: Mechanisms of neurodegeneration/neuroprotection
    Associate Professor in the Department of Biochemistry and Molecular Biology at Louisiana State University Health Science Center, Shreveport, LA, USA

    Peter Illes, MD

    Section: Neuron-glia protective interactions
    Emeritus Professor of Pharmacology, University of Leipzig, Germany

    Tauheed Ishrat, PhD

    Section: Neurological alterations caused by diabetes and metabolic diseases
    Associate Professor, Department of Anatomy & Neurobiology, College of Medicine, University of Tennessee, Tennessee, USA

    Jayantee Kalita, MD, DM

    Section: Rare neurodegenerative diseases
    Professor, Department of Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow-226014, Uttar Pradesh, India

    José L. Lanciego, PhD

    Section: Translational research on neuroprotection
    Staff Scientist at the Department of Neurosciences, Center for Applied Medical Research, and Associate Professor of Neurosciences at the University of Navarra Medical School, Pamplona, Spain

    Weidong Le, MD, PhD

    Section: Biomarkers
    Professor and Vice Dean, Medical School and Director of Neurology Institute, Sichuan Academy of Medical Sciences-Sichuan Provincial Hospital, Chengdu, China;
    Professor and Director of Center for Translational Research on Neurology Disease, the 1st Affiliated Hospital of Dalian Medical University, Dalian, China

    Jorge Manzanares, PhD

    Section: Mental health and addictive disorders
    Professor of Pharmacology, Universidad Miguel Hernández.CSIC, San Juan de Alicante, Alicante, Spain;
    Adjunct Professor of Psychiatry, Department of Psychiatry, New York University, New York, USA

    Zixu Mao, MD, PhD

    Section: Neural stress response and signaling
    Professor, Department of Pharmacology and Chemical Biology and Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA

    Thomas Müller, MD

    Section: Chronic neurodegeneration with a focus on dementia and Alzheimer's disease
    Professor at Department of Neurology, St. Joseph Hospital Berlin-Weissensee, Berlin, Germany

    Hyun-Ock Pae, PhD

    Section: Microglia-mediated neuroprotection
    Professor, Department of Microbiology & Immunology, School of Medicine, Wonkwang University, Iksan, Republic of Korea

    Vijay K. Sharma, MD

    Section: Regulatory challenges
    Associate Professor, Yong Loo Lin School of Medicine, National University of Singapore;
    Senior Consultant, Division of Neurology, Department of Medicine, National University Hospital, Singapore

    Christopher A. Shaw, PhD

    Section: Amyotrophic lateral sclerosis
    Professor at The University of British Columbia, Vancouver, Canada

    Henning Ulrich, PhD

    Section: Synucleopathies and Parkinson’s disease
    Full Professor and Head of the Laboratory of Neuroscience at the Dep. of Biochemistry at the Institute of Chemistry of the University of São Paulo, Brazil
    Editorial Board Members

    Diana Amantea, PhD

    Interests: ischemic stroke; neuroinflammation; neuroprotection
    Associate Professor of Pharmacology at the Department of Pharmacy, Health and Nutritional Sciences of the University of Calabria, Rende (CS), Italy;
    leader of the Stroke Research Unit at the Center of Preclinical and Translational Pharmacology, University of Calabria, Rende (CS), Italy

    Noureddin Nakhostin Ansari, PhD

    Interests: neurorehabilitation; physiotherapy; spasticity; stroke
    Professor of Physiotherapy at School of Rehabilitation, Tehran University of Medical Sciences (TUMS), Tehran, Iran

    Giulia Bivona, MD

    Interests: biomarkers; clinical biochemistry; laboratory medicine; vitamin D
    Investigator, Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, Palermo, Italy

    Jun Cai, MD, PhD

    Interests: glial interaction; gene-environment interaction; neural development; neuroinflammation; neurotrauma
    Associate Professor, Pediatric Research Institute, Department of Pediatrics, and Department of Pharmacology & Toxicology, University of Louisville School of Medicine, Kentucky, USA

    Yujie Chen, MD, PhD

    Interests: subarachnoid hemorrhage; intracerebral hemorrhage; blood-brain barrier; pericyte; neuroinflammation
    Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, China

    Volonté Cinzia, PhD

    Interests: neurodegeneration; neuroinflammation; purinergic signalling; drug targets
    Research Director at National Research Council (CNR-IASI Institute) in Rome, Italy

    Cristoforo Comi, MD, PhD

    Interests: neurodegenerative diseases; neuroimmunology; Parkinson's disease; multiple sclerosis; Alzheimer's disease
    Associate Professor of Neurology, Head of the Multiple Sclerosis Center, and the Movement Disorders Center, University of Piemonte Orientale, Novara, Italy

    Jesús Devesa, MD, PhD

    Interests: growth hormone; IGF-I; melatonin; neurorehabilitation; TBI
    Professor of Physiology, Scool of Medicine, University of Santiago de Compostela, Santiago de Compostela, Galicia, Spain;
    Scientific director of the Foundation Foltra and Medical Center Foltra, Teo, Galicia, Spain

    Kuo-Sheng Hung, MD, PhD

    Interests: precision medicine; new drugs; neuroprotection; genetics; osteoporosis
    Professor, Department of Neurosurgery, Wan Fang Hospital, Graduate Institute of Injury Prevention and Control, College of Public Health, Taipei Medical university, Taipei, Taiwan, China

    Antonio Ibarra, PhD

    Interests: spinal cord injury; cerebral ischemia; cognitive impairment; neuroprotection; neuroregeneration; immunonutrition
    Professor of Medicine and Clinical Immunology at Anahuac University, Senior Researcher; and Coordinator of the Health Sciences Research Center (CICSA), Anahuac University, Mexico